Search Clinical Trials
Completed
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence (External Link)
The purpose of this study is to evaluate the interactions between cocaine and oral rivastigmine and between cocaine and oral huperzine A (HupA). The following Specific Aims are proposed: 1. …
Baylor Role:
Lead Sponsor
Withdrawn
Varenicline-Methamphetamine Interaction Study (2008) (External Link)
See Brief Summary
Baylor Role:
Lead Sponsor
Completed
A Study of the Relationship Between Disulfiram and Cocaine Self-administration. (External Link)
The problem of cocaine dependence remains a major medical, social, and legal concern. Several studies have suggested that disulfiram may be beneficial for the treatment of cocaine dependence. A common …
Baylor Role:
Lead Sponsor
Completed
Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts (External Link)
Heroin addiction is a serious health problem with no available medical treatment for preventing relapse. Naltrexone is a medication that is currently used to treat substance addiction. It acts by …
Baylor Role:
Lead Sponsor
Completed
Pharmacogenetics of Disulfiram for Cocaine (External Link)
Dopamine, a type of neurotransmitter, is the brain's "feel good" chemical. The amount of dopamine in the body may be an important factor in how cocaine addicts respond to treatment. …
Baylor Role:
Lead Sponsor